- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 307/02 - Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
Patent holdings for IPC class C07C 307/02
Total number of patents in this class: 114
10-year publication summary
6
|
7
|
3
|
11
|
7
|
5
|
10
|
15
|
7
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Zevra Therapeutics, Inc. | 99 |
7 |
Celgene Corporation | 1395 |
4 |
Sumitomo Chemical Company, Limited | 9047 |
3 |
Anhui Jinhe Industrial Co., Ltd. | 89 |
3 |
Bio-Pharm Solutions Co., Ltd. | 60 |
3 |
Creative Therapeutics GmbH | 5 |
3 |
Emory University | 1629 |
3 |
Tokyo Ohka Kogyo Co., Ltd. | 1549 |
3 |
Axsome Malta Ltd. | 75 |
3 |
Boehringer Ingelheim Pharmaceuticals, Inc. | 76 |
2 |
FUJIFILM Corporation | 29543 |
2 |
Shin-Etsu Chemical Co., Ltd. | 5685 |
2 |
Daikin Industries, Ltd. | 10070 |
2 |
Board of Regents, The University of Texas System | 5849 |
2 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2179 |
2 |
Central Glass Company, Limited | 1271 |
2 |
Chugai Seiyaku Kabushiki Kaisha | 1367 |
2 |
Epizyme, Inc. | 374 |
2 |
Gilead Sciences, Inc. | 2045 |
2 |
Metabasis Therapeutics, Inc. | 39 |
2 |
Other owners | 60 |